TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Cost per patient at 3 months
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Cost per patient at 12 months
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Neutralization antibody titers of 1:40 or greater
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Pain-related disability reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 80% reduction in PASI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: total clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Mean facet luminance scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean infratip luminance scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean facet/infratip luminance ratios
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean reduction in total cost
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: average total daily step count
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SPPB summary score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Posterior capsule opacification (PCO)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: crying duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: success rate of the R&R procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean exodeviations at distance and near
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of infiltrative events
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Interobserver agreement for HV angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intraobserver agreement for HV angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Interobserver agreement for 1-2 IM angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intraobserver agreement for 1-2 IM angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Arterial Pressure (MAP) reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Reduction of FSH, LH, LH/FSH and T
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Mean PPD changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BOP changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success rate of atrial septum puncture
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in LA pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Improvement of clinical symptoms
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: percentage of opiate-negative urine specimens
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: duration of sustained abstinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-reported frequency of use
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Time taken for tracheal intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time interval for mask removal after successful intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Seizure comfort scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Overall clinic appointment no shows
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Return to baseline of gastrin and CgA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Absence of rebound dyspepsia after esomeprazole withdrawal
Endpoint domain: Adverse events/effects
Primary endpoint: Cost-effectiveness of rituximab compared to abatacept and TNFi
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: evening snacking of high-fat foods
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy on attention network task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Variability on attention network task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sputum mucins
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: airway neutrophil recruitment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Favorable self-perception of oral health
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Frequency of brushing and flossing teeth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dental check-up visits
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: objective risk comprehension
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: worry about Crohn's disease
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Examination of all moles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Skin cancer examination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Routine use of sunscreen
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Coronary artery spasms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: cumulative incidence of chlamydia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Observational Gait Scale total scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in Madsen score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complications during treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of participants compliant with intervention
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: odds of death
Endpoint domain: Mortality/survival
Primary endpoint: TRL apo B‐48 and VLDL apo B‐100 kinetics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Retrieval time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Assessment of ADD behaviors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of desensitized patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median eliciting dose of hazelnut protein
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean changes in BCVA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Retention at 12 months
Endpoint domain: Life impact
Endpoint subdomain: Other resource use
Primary endpoint: median operative blood loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: median gallbladder dissection time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in TSH concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Quality of life assessed using EQ-5D
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Estimated mean QALYs
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: OCT % neointimal volume obstruction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Improvements in walking ability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceived rating of the effects of physical limitations on quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Time until recurrence of arthritis
Endpoint domain: Mortality/survival
Primary endpoint: Postoperative best spectacle-corrected visual acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative refraction within +/- 0.50 D of emmetropia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative higher order aberrations
Endpoint domain: Adverse events/effects
Primary endpoint: Reliability of biomarkers of intestinal permeability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Reliability of adipose tissue inflammation measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Craving for beverages
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: subglottic pressure levels during swallowing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients maintaining viral load below 50 copies/ml
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean CD4(+) cell count increase from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients experiencing treatment-related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Mean percentage reduction in papules and pustules
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall rosacea severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physician Global Assessment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percentage of patients reaching testosterone levels <20 ng/dl
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: emotional quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Postoperative morbidity and mortality
Endpoint domain: Adverse events/effects
Primary endpoint: change in prebronchodilator FEV(1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Combined endpoint (death, nonfatal infarction or repeat revascularization)
Endpoint domain: Mortality/survival
Primary endpoint: Clinical restenosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Hepatic fat fraction (HFF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: lip fullness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: perioral lines
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: oral commissures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of CIN III or worse
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: days hospitalized for cardiovascular causes or death within 60 days
Endpoint domain: Mortality/survival
Primary endpoint: HiSCR week-36 rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: peak inspiratory capacity (IC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: activity-related energy expenditure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: average number of steps per day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: global pain relief
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: catastrophizing scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Time to locate the epidural space
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pCR rate of HER2-positive breast cancers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: frequencies of cardiac toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: first occurrence of nonfatal myocardial infarction, nonfatal stroke, or all cause death
Endpoint domain: Mortality/survival
Primary endpoint: mean height-for-age z score (haz)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: platelet activation state
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Variability of capillary blood glucose values (MAGE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of severe hypoglycaemic events
Endpoint domain: Adverse events/effects
Primary endpoint: intention to smoke
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: withdrawal-related craving
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: latency to self-administration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Asthma exacerbations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FEF(25‐75%) value
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median time from initial facility contact to clinic enrollment
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Mean changes in weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative bowel obstruction
Endpoint domain: Adverse events/effects
Primary endpoint: Infarct-related coronary artery patency (TIMI grade 2 or 3) at 90 minutes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Complete patency (TIMI grade 3) at 90 minutes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Need for acute additional coronary interventions
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Time to virus clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Development of Metabolic Syndrome (MetS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Median pain score at 8 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of hematoma formation
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of localized signs of infection
Endpoint domain: Adverse events/effects
Primary endpoint: Mean capillary glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rod b-wave amplitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Combined rod-cone response amplitudes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Refractive outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: continence for gas and liquids
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: neurocognitive performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: peripheral serum BDNF level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: levels of inflammatory cytokines (TNF-α, IL-15)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: error
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adherence to otitis media guidelines
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Unified PD Rating score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Motor Unified PD Rating score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: T cell markers (IL‐2R, TR, CD3/HLA‐DR) in ulcerative colitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: T cell markers (CD3, TCR alpha/beta, TCR gamma/delta) in Crohn's disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Differences in lymphocyte markers (CD19, TR, TCR alpha/beta, TCR gamma/delta) between ulcerative colitis and Crohn's disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: composite ischemic endpoint
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Motor Bayley scores of <70
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mental Bayley scores of <70
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage defect resolution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feelings of security regarding medical information
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Anxiety levels related to medical information
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: percentage time with intragastric pH >4
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: prolonged hospitalization
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Current CRC screening status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete fusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Size of fusion masses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: stance phase symmetry ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ankle range of motion in the sagittal plane
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maximal dorsiflexion angle during terminal stance phase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ankle power
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of pleural drainage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: C-peptide AUC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Disposition index for insulin and C-peptide
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Improvement in diarrhea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: perceived ability to function despite pain
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Serum HDL-C levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: creatine kinase MB isoenzyme levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: UPDRS‐III motor symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Gait improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Postural stability improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Postoperative pain measured by Numerical Rating Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median time to acetaminophen
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median time to troponin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median ED length of stay
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: ECF treatment effect
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cancers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Levels of HDL-C
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Levels of TC/HDL-C
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Levels of FSH
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Albuterol use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 30-day graft occlusion rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: modified Rankin score 0–1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: vigorous exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Survival free from stroke, myocardial infarction, and repeat revascularization
Endpoint domain: Mortality/survival
Primary endpoint: Quality-adjusted lifetime
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: DFO-related neurological/ophthalmological side-effects
Endpoint domain: Adverse events/effects
Primary endpoint: serum aluminium levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: residual diuresis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Believability of alternative thoughts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IKS score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GAIS evaluations indicating aesthetic improvement
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Abnormal electrogastrograms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes